The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies

Lignende værker

• Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
  af: Jacobsen, Paula L., et al.
  Udgivet: (2015)
• Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
  af: Alam, Mohammed Y., et al.
  Udgivet: (2014)
• Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension
  af: Aman, Michael G., et al.
  Udgivet: (2017)
• Efficacy of vortioxetine on the physical symptoms of major depressive disorder
  af: Christensen, Michael Cronquist, et al.
  Udgivet: (2018)
• A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders
  af: Findling, Robert L., et al.
  Udgivet: (2018)